The Acute Myeloid Leukemia (AML) market is witnessing significant advancements driven by innovative therapies and increasing disease prevalence worldwide. As cancer therapeutics evolve, the AML market reflects a dynamic landscape characterized by strategic developments from top pharmaceutical companies and expanding treatment options, fueling robust business growth and market...